Patient#	Sample#	BSG:(BSG, protein),	CASK:(CASK, protein),	CCL5:(CCL5, protein),	Collagen:(Collagen, protein),	ERK1-2:(ERK1-2, protein),	HPSE:(HPSE, protein),	LAMA5:(LAMA5, protein),	MMP7:(MMP7, protein),	MMP9_107-707:(MMP9_107-707, protein),	MMP1:(MMP1, protein),	PPIB:(PPIB, protein),	SDCBP:(SDCBP, protein),	PRKACA:(PRKACA, protein),	SDC1:(HPSE, active),(MMP1, active),(MMP7, active),(MMP9_107-707, active),(PRKACA, active),(SDC1, protein),(TGFB1/TGF beta receptor Type II, active),	FGFR/FGF2/Syndecan-1:(FGFR/FGF, active),(SDC1, active),	Syndecan-1/CASK:(CASK, active),(SDC1, active),	Syndecan-1/Collagen:(Collagen, active),(SDC1, active),	Syndecan-1/HGF/MET:(HGF/MET, active),(SDC1, active),	Syndecan-1/Laminin-5:(LAMA5, active),(SDC1, active),	Syndecan-1/CD147:(BSG, active),(PPIB, active),(SDC1, active),(T-Lymphocyte, active),	Syndecan-1/RANTES:(CCL5, active),(SDC1, active),	Tumor Cell Invasion:(SDC1, active),	positive regulation of cell migration:(SDC1, active),	ERK1-2-active:(ERK1-2, active),(ERK1-2-active, protein),(Syndecan-1/CD147, active),	Syndecan-1/Syntenin:(SDC1, active),(SDCBP, active),	homophilic cell adhesion:(Syndecan-1/Collagen, active),	Syndecan-1/Syntenin/PIP2:(PI-4-5-P2, active),(Syndecan-1/Syntenin, active),	keratinocyte migration:(Syndecan-1/Laminin-5, active),	regulation of cell adhesion:(ERK1-2-active, active),	positive regulation of cell-cell adhesion:(Syndecan-1/Syntenin/PIP2, active),	
